SNY – Sanofi

SNY — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.31

Margin Of Safety %

Put/Call OI Ratio

1.03

EPS Next Q Diff

0.22

EPS Last/This Y

1.23

EPS This/Next Y

0.32

Price

46.78

Target Price

56.9

Analyst Recom

1.71

Performance Q

-3.27

Upside

-33.6%

Beta

0.42

Ticker: SNY

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	SNY	48.66	1.03	1.47	56208
2026-03-03	SNY	46.5	1.00	0.49	57403
2026-03-04	SNY	46.24	0.99	0.32	58022
2026-03-06	SNY	44.52	0.98	0.30	59022
2026-03-09	SNY	44.38	0.97	1.43	59538
2026-03-10	SNY	44	0.98	1.33	61813
2026-03-11	SNY	43.97	0.97	3.66	61836
2026-03-12	SNY	43.65	0.98	0.29	62160
2026-03-13	SNY	43.63	0.98	0.43	62160
2026-03-17	SNY	44.09	0.96	0.06	61855
2026-03-18	SNY	43.72	0.94	1.87	62501
2026-03-20	SNY	44.64	0.92	2.62	62850
2026-03-25	SNY	46.06	1.12	0.06	50967
2026-03-26	SNY	46.62	1.07	0.33	52307
2026-03-27	SNY	46.8	1.03	0.69	53963
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	SNY	48.67	4.2	6199.7	5.00
2026-03-02	SNY	47.69	4.2	5455.8	5.01
2026-03-03	SNY	46.48	4.2	5448.5	5.01
2026-03-04	SNY	46.23	4.2	5621.1	5.01
2026-03-05	SNY	45.00	4.2	5392.8	5.01
2026-03-06	SNY	44.53	4.2	5588.7	5.01
2026-03-09	SNY	44.36	4.2	5596.8	5.01
2026-03-10	SNY	43.99	4.2	5576.4	5.01
2026-03-11	SNY	43.97	4.2	5343.3	5.01
2026-03-12	SNY	43.66	4.2	3784.6	5.01
2026-03-13	SNY	43.60	4.2	3733.7	5.01
2026-03-17	SNY	44.09	4.2	3851.1	5.01
2026-03-18	SNY	43.71	4.2	3694.4	5.01
2026-03-19	SNY	45.36	4.2	4191.6	5.01
2026-03-20	SNY	44.60	4.2	3489.5	5.01
2026-03-23	SNY	44.79	4.2	3584.3	5.01
2026-03-24	SNY	45.13	4.2	3791.6	5.01
2026-03-25	SNY	46.06	4.2	3876.2	5.01
2026-03-26	SNY	46.60	4.2	3835.5	5.01
2026-03-27	SNY	46.78	4.2	3733.3	5.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	SNY	0.00	-4.71	0.33
2026-03-02	SNY	0.00	-4.41	0.33
2026-03-03	SNY	0.00	-4.41	0.33
2026-03-04	SNY	0.00	-4.41	0.33
2026-03-05	SNY	0.00	-4.41	0.33
2026-03-06	SNY	0.00	-4.41	0.33
2026-03-09	SNY	0.00	0.46	0.33
2026-03-10	SNY	0.00	0.46	0.33
2026-03-11	SNY	0.00	0.46	0.27
2026-03-12	SNY	0.00	0.46	0.27
2026-03-13	SNY	0.00	0.46	0.27
2026-03-17	SNY	0.00	-0.31	0.27
2026-03-18	SNY	0.00	-0.31	0.27
2026-03-19	SNY	0.00	-0.31	0.27
2026-03-20	SNY	0.00	-0.31	0.27
2026-03-23	SNY	0.00	-0.08	0.27
2026-03-24	SNY	0.00	-0.08	0.27
2026-03-25	SNY	0.00	-0.08	0.31
2026-03-26	SNY	0.00	-0.08	0.31
2026-03-27	SNY	0.00	-0.08	0.31
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.89

Avg. EPS Est. Current Quarter

1.07

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

Institutional Transactions

-0.08

Beta

0.42

Average Sales Estimate Current Quarter

10000

Average Sales Estimate Next Quarter

10745

Fair Value

59.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

22.2

Max Drawdown 5-Year %

-33.5

Target Price

56.9

P/E

19.59

Forward P/E

8.85

PEG

1.2

P/S

2.27

P/B

1.35

P/Free Cash Flow

10.71

EPS

2.39

Average EPS Est. Cur. Y

5.01

EPS Next Y. (Est.)

5.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.81

Relative Volume

0.89

Return on Equity vs Sector %

-21.9

Return on Equity vs Industry %

-31.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.12

EBIT Estimation

3733.3

◆ SNY Healthcare

$46.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

10/25

Volume

7/15

Valuation

18/20

TP/AR

1/10

Options

2/10

RSI

58.4

Range 1M

76.8%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

10/30

Estimates

5/20

Inst/Vol

0/15

Options

5/10

EPS Yr

EPS NY

6.8%

52W%

28.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +36.6% upside

Quality

14/30

Valuation

15/30

Growth

8/25

Stability

4/10

LT Trend

1/5

Upside

+36.6%

Quality

MoS

27%

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. Sanofi has a strategic collaboration with miRecule, Inc. to facilitate the advancement of therapy DUX4, a genetic driver of debilitating muscular disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y